Literature DB >> 30756119

Factors Associated with Alzheimer's Disease: An Overview of Reviews.

M Rochoy1, V Rivas, E Chazard, E Decarpentry, G Saudemont, P-A Hazard, F Puisieux, S Gautier, R Bordet.   

Abstract

Alzheimer's disease (AD) is a frequent pathology, with a poor prognosis, for which no curative treatment is available in 2018. AD prevention is an important issue, and is an important research topic. In this manuscript, we have synthesized the literature reviews and meta-analyses relating to modifiable risk factors associated with AD. Smoking, diabetes, high blood pressure, obesity, hypercholesterolemia, physical inactivity, depression, head trauma, heart failure, bleeding and ischemic strokes, sleep apnea syndrome appeared to be associated with an increased risk of AD. In addition to these well-known associations, we highlight here the existence of associated factors less described: hyperhomocysteinemia, hearing loss, essential tremor, occupational exposure to magnetic fields. On the contrary, some oral antidiabetic drugs, education and intellectual activity, a Mediterranean-type diet or using Healthy Diet Indicator, consumption of unsaturated fatty acids seemed to have a protective effect. Better knowledge of risk factors for AD allows for better identification of patients at risk. This may contribute to the emergence of prevention policies to delay or prevent the onset of AD.

Entities:  

Keywords:  Alzheimer’s disease; early intervention; prevention; risk factors

Year:  2019        PMID: 30756119     DOI: 10.14283/jpad.2019.7

Source DB:  PubMed          Journal:  J Prev Alzheimers Dis        ISSN: 2274-5807


  6 in total

1.  Hearing loss is an early biomarker in APP/PS1 Alzheimer's disease mice.

Authors:  Yang Liu; Shu Fang; Li-Man Liu; Yan Zhu; Chang-Ri Li; Kaitian Chen; Hong-Bo Zhao
Journal:  Neurosci Lett       Date:  2019-12-20       Impact factor: 3.046

2.  Design, Synthesis and Biological Evaluation of New 3,4-Dihydro-2(1H)-Quinolinone-Dithiocarbamate Derivatives as Multifunctional Agents for the Treatment of Alzheimer's Disease.

Authors:  Jie Guo; Airen Xu; Maojun Cheng; Yang Wan; Rikang Wang; Yuanying Fang; Yi Jin; Sai-Sai Xie; Jing Liu
Journal:  Drug Des Devel Ther       Date:  2022-05-18       Impact factor: 4.319

3.  Association between Apoϵ4 allele and cardiometabolic and social risk factors with cognitive impairment in elderly population from Bogota.

Authors:  Olga Lucia Pedraza; Isis Camacho; Fabio Alexander Sierra; Rubio-Gómez Cladelis; Ana Maria Salazar; Maria Camila Montalvo; Hector Daniel Morillo; Angela Lozano; Luz Dary Gutiérrez-Castañeda; Lilian Torres-Tobar; Cesar Piñeros
Journal:  Dement Neuropsychol       Date:  2021 Oct-Dec

Review 4.  Dietary and Nutrient Patterns and Brain MRI Biomarkers in Dementia-Free Adults.

Authors:  Archontoula Drouka; Eirini Mamalaki; Efstratios Karavasilis; Nikolaos Scarmeas; Mary Yannakoulia
Journal:  Nutrients       Date:  2022-06-03       Impact factor: 6.706

Review 5.  Disease-specific interactome alterations via epichaperomics: the case for Alzheimer's disease.

Authors:  Stephen D Ginsberg; Thomas A Neubert; Sahil Sharma; Chander S Digwal; Pengrong Yan; Calin Timbus; Tai Wang; Gabriela Chiosis
Journal:  FEBS J       Date:  2021-06-12       Impact factor: 5.622

Review 6.  The Beneficial Role of Natural Endocrine Disruptors: Phytoestrogens in Alzheimer's Disease.

Authors:  Anita Domańska; Arkadiusz Orzechowski; Anna Litwiniuk; Małgorzata Kalisz; Wojciech Bik; Agnieszka Baranowska-Bik
Journal:  Oxid Med Cell Longev       Date:  2021-09-03       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.